Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted CAGR for the Tissue Heart Valves Market Over the Forecast Period of 2025 to 2034?

The market for tissue heart valves has seen a consistent rise in recent times. The market size is projected to rise from $1.48 billion in 2024 to $1.53 billion in 2025, reflecting a compound annual growth rate (CAGR) of 3.1%. The recorded growth in the past could be associated with an increase in lifestyle-related illnesses, escalating healthcare spending, a surge in the elderly populace, a rise in cardiac and pathological disorders, and an upswing in cases of heart diseases.

Anticipations indicate a consistent growth in the tissue heart valves market in the following years. The market is projected to hit a value of $1.70 billion by 2029, with a compound annual growth rate (CAGR) of 2.7%. Factors such as a higher incidence of cardiovascular disorders, an incline towards sutureless operations, the growth of the elderly population, escalating demand for cardiovascular treatments, and evolving healthcare investments are driving this growth for the forecast period. Technological advancement, the development of original culture systems, progression in imaging technologies, enhancement in surgical procedures, and market expansion in developing countries are the major trends to watch for the projected period.

What Industry-Specific Factors Are Fueling the Growth of the Tissue Heart Valves Market?

The escalating occurrence of cardiovascular diseases is anticipated to drive the expansion of the tissue heart valves market in the future. Cardiovascular disorders encompass a range of conditions impacting the heart and blood vessels such as strokes, heart attacks, and hypertension. The rising incidence of cardiovascular diseases is primarily influenced by aspects like unhealthy lifestyles, aging demographics, increased presence of risk elements, poor eating habits, lack of physical activity, smoking, stress, and urbanization, all contributing to a global increase in heart-related conditions. Tissue heart valves play a vital role in combating cardiovascular diseases by offering patients needing valve replacements with a solution that is biocompatible, durable, and has low thrombogenicity, which enhances long-term heart functioning and minimizes the likelihood of complications. For instance, reports from the Heart Failure Society of America (HFSA), a professional organization based in the US, noted in September 2024 that approximately 6.7 million Americans aged 20 and above are presently coping with heart failure, with predictions suggesting a rise to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050. Consequently, the escalating occurrence of cardiovascular diseases propels the expansion of the tissue heart valve market.

Explore Comprehensive Insights Into The Global Tissue Heart Valves Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21302&type=smp

Who are the key firms paving the way for growth in the Tissue Heart Valves market?

Major companies operating in the tissue heart valves market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, LifeNet Health Inc., TTK Healthcare Ltd., Braile Biomédica, On-X Life Technologies Inc., Anteris Technologies Ltd., Labcor Laboratórios Ltd., CARDION s.r.o., CryoLife Inc., Colibri Heart Valve LLC, Foldax Inc., Balance Medical Technologies Co. Ltd., MiCardia Corporation, Neovasc Inc.

What Key Trends Are Currently Impacting the Tissue Heart Valves Market’s Development?

Key businesses in the tissue heart valves market are prioritizing the creation of novel products such as surgical aortic tissue valves, aiming to provide simplicity during the implanting process and for ongoing patient care. A surgical aortic tissue valve, usually utilized to replace a diseased or worn-out aortic valve during heart surgery, is a prosthetic heart valve fabricated from biological tissue. For example, in June 2024, Medtronic plc., a technologically focused company based in Ireland, introduced the Avalus Ultra valve. This is a cutting-edge surgical aortic tissue valve, developed to simplify its application during surgery and assist with long-term patient care. With a decade’s clinical experience with the Avalus valve, this new development possesses a low valve profile, a Polyetheretherketone (PEEK) base frame which ensures consistent roundness, and a market-leading Effective Orifice Area (EOA) for enhanced blood circulation. The valve also features a radiopaque coil for clear visibility during future valve-in-valve procedures, ensuring long-lasting reliability for patients suffering from aortic stenosis.

Secure Your Global Tissue Heart Valves Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/tissue-heart-valves-global-market-report

Which Segments Play a Crucial Role in the Expansion of the Tissue Heart Valves Market?

The tissue heart valves market covered in this report is segmented –

1) By Type: Stented Tissue Heart Valves, Stentless Tissue Heart Valves

2) By Valve Type: Aortic, Mitral, Tricuspid, Pulmonary

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Stented Tissue Heart Valves: Bovine Pericardial Valves, Porcine Valves

2) By Stentless Tissue Heart Valves: Bovine Pericardial Stentless Valves, Homograft Valves

Which Geographical Regions Are Pioneering Growth in the Tissue Heart Valves Market?

North America was the largest region in the tissue heart valves market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue heart valves market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Do Experts Define the Scope of the Tissue Heart Valves Market?

Tissue heart valves are heart valves made from biological tissue (rather than mechanical materials) used in heart valve replacement surgeries. They are often used as an alternative to mechanical heart valves and are designed to mimic the function of natural heart valves.

Browse Through More Similar Reports By The Business Research Company:

Hepatitis B Virus (HBV) Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hepatitis-b-virus-hbv-global-market-report

Viral Hepatitis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Hepatitis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: